Treatment of primary central nervous system lymphoma with induction of complement-dependent cytotoxicity by intraventricular administration of autologous-serum-supplemented rituximab.

Bibliographic Information

Title
Treatment of primary central nervous system lymphoma with induction of complement-dependent cytotoxicity by intraventricular administration of autologous-serum-supplemented rituximab.
Author
Takami A, et al.

Journal

Related Projects

See more

Details

  • CRID
    1010282256798393223
  • Article Type
    journal article
  • Data Source
    • KAKEN

Report a problem

Back to top